The demonstration that HIF-1 mediates increased expression of TAZ and its positive regulator SIAH1 is conceptually similar to our finding that HIFs mediate the expression of Rho Kinase 1 and its positive regulator Rho A to stimulate the motility of hypoxic breast cancer cells [19]. The gene discussed is HIF1A; the disease is breast carcinoma.